Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Raw Materials (2019 - 2025)

Pulmonx (LUNG) has disclosed Raw Materials for 7 consecutive years, with $4.3 million as the latest value for Q3 2025.

  • Quarterly Raw Materials rose 26.29% to $4.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Sep 2025, up 26.29% year-over-year, with the annual reading at $3.4 million for FY2024, 16.48% up from the prior year.
  • Raw Materials for Q3 2025 was $4.3 million at Pulmonx, up from $3.9 million in the prior quarter.
  • The five-year high for Raw Materials was $4.3 million in Q3 2025, with the low at $2.9 million in Q3 2023.
  • Average Raw Materials over 5 years is $3.5 million, with a median of $3.4 million recorded in 2024.
  • The sharpest move saw Raw Materials dropped 23.46% in 2023, then skyrocketed 30.01% in 2025.
  • Over 5 years, Raw Materials stood at $3.7 million in 2021, then increased by 2.19% to $3.8 million in 2022, then decreased by 23.46% to $2.9 million in 2023, then increased by 16.48% to $3.4 million in 2024, then increased by 24.96% to $4.3 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $4.3 million, $3.9 million, and $3.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.